| SpectraBase Spectrum ID |
5ZKYBK3dE2K |
| Name |
5-APDI N-(3-bromobenzyl) |
| Classification |
Amphetamine designer drug |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
343.093562712 u |
| Formula |
C19H22BrN |
| InChI |
InChI=1S/C19H22BrN/c1-14(21-13-16-4-2-7-19(20)12-16)10-15-8-9-17-5-3-6-18(17)11-15/h2,4,7-9,11-12,14,21H,3,5-6,10,13H2,1H3 |
| InChIKey |
DJPSVVNFENPLSF-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
344.296 g/mol |
| Nominal Mass |
343 u |
| Quality |
985 |
| Retention Index |
2422 |
| SMILES |
C1=2C(=CC=C(C2)CC(NCC=2C=C(C=CC2)Br)C)CCC1 |
| SPLASH |
splash10-03di-1590000000-604715cb2891678ab881 |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
N-(3-Bromobenzyl)-1-(indan-5-yl)propan-2-amine
N-(3-Bromobenzyl)-1-(2,3-dihydro-1H-inden-5-yl)propan-2-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_021144 |
